Table 4

Health status measured at baseline (T0), end of intervention (T1), and 12 weeks follow-up (T2) (n = 13)

T0

T1

p-value (T0-T1)

T2

p-value (T0-T2)


HAQ (0-3)

0.5 (0.0-1.5)

0.5 (0.0-1.2)

0.72

0.5 (0.0-1.5)

0.34

Fatigue (0-100)

27 (5 - 89)

28 (3 - 81)

0.55

25 (6 - 74)

0.70

Muscle pain (0-100)

30 (1 - 60)

25 (2 - 69)

0.92

23 (2 - 61)

0.88

Fear of falling (0-100)

14 (0 -76)

21 (2 - 71)

0.75

33 (10-95)

0.13

SF-36 (0-100)

Vitality

45 (15 - 80)

55 (35 - 70)

0.26

50 (25 - 70)

0.59

Pain

51 (0 - 84)

62 (41 - 84)

0.05

42 (22 - 100)

0.17

General health

52 (35 - 82)

50 (32 - 87)

0.96

47 (35 - 97)

0.92

Mental health

80 (40 - 92)

76 (36 - 92)

0.68

76 (56 - 92)

0.59

Physical functioning

75 (25 - 95)

70 (30 - 95)

0.72

75 (25 - 95)

0.91

Social functioning

75 (12 - 100)

75 (25 - 100)

0.03

62 (12 - 100)

0.22

Role emotional

100 (0 - 100)

100 (33 - 100)

0.23

67 (0 - 100)

0.86

Role physical

50 (0 - 100)

75 (0 - 100)

0.19

25 (0 - 100)

0.91

Self-efficacy (10-100)

Pain

NA

70 (18 - 100)

NA

62 (18 - 86)

0.45*

Function

89 (54 - 100)

88 (28 - 99)

0.40

90 (61 - 100)

0.22

Symptoms

75 (35 - 90)

75 (42 - 100)

0.45

78 (57-97)

0.13


Values are median (range).

*T1 versus T2

NA = not assessed

HAQ = Health Assessment Questionnaire

SF-36 = Short Form Health Survey 36

Uhlig et al. BMC Musculoskeletal Disorders 2010 11:43   doi:10.1186/1471-2474-11-43

Open Data